Ligand Pharmaceuticals Incorporated Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Ligand Pharmaceuticals Incorporated (LGND) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-4.0352.15-33.3657.14-2.99629.30143.32
Depreciation & Amortization35.2434.5751.5350.9527.9763.4514.72
Deferred Income Tax-15.8011.7020.72-8.620.000.0029.74
Stock Based Compensation41.0925.7460.2938.7830.730.000.00
Change in Working Capital19.36-22.7165.68-57.00-11.6782.78-41.78
Change in Accounts Receivable-6.46-2.6055.32-28.62-26.060.000.00
Change in Inventory9.62-10.8712.06-0.43-17.800.000.00
Change in Accounts Payable0.00-4.70-3.342.81-1.250.000.00
Change in Other Working Capital6.706.045.87-8.93-4.950.000.00
Other Operating Activities6.70-14.145.87-36.71-15.437.9483.04
Net Cash from Operating Activities97.0549.58137.8578.8054.59-29.34194.06
Investing Activities
Capital Expenditures-19.643.52-17.92-8.76-4.462.55-0.89
Acquisitions-172.19-10.41-0.750.00-404.88-12.84-5.86
Purchases of Investments-226.38-126.76-51.2340.01615.670.000.00
Sales/Maturities of Investments269.6217.49234.390.491.36-330.49-409.44
Other Investing Activities-12.89-49.91-0.87-1.221.90-4.672.91
Net Cash from Investing Activities-143.66-11.68163.6230.52231.65466.92-423.27
Financing Activities
Debt Repayment-0.03-77.85-261.00-164.95-231.76-27.32-217.67
Common Stock Issued37.1422.453.2333.763.02-453.05-122.87
Common Stock Repurchased0.00-4.55-8.24-6.02-79.480.000.00
Other Financing Activities-5.56-4.55-18.22-0.56-2.33-7.42-191.06
Net Cash from Financing Activities97.14-59.95-275.99-137.76-310.55-485.17328.59
Summary
Effect of Forex Changes on Cash-1.170.000.000.000.000.00-0.22
Net Change in Cash50.52-22.0525.48-28.44-24.31-47.5999.38
Cash at Beginning of Period22.9545.0119.5247.9672.27119.7820.62
Cash at End of Period72.3145.0145.0119.5247.9672.27119.78
Free Cash Flow77.4146.06119.9370.0450.13780.91183.17
Supplemental Disclosures
Interest Paid0.260.291.433.034.465.831.51
Income Taxes Paid19.218.7711.643.722.13103.820.34